Symmetry Partners, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1697493 GLASTONBURY, CT

Position in REGN

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$222,520

+$5,625 QoQ

Shares Held

288

+2.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

19 quarters on record

Voting authority Sole 53% Shared 0% None 47%

Healthcare · as of Jun 30, 2026

Symmetry Partners, LLC holds $289,294 across 1 Biotechnology name.

#	Ticker	Company	Shares	Value (USD)	Open
1	INCY	Incyte Corp	2,552	$289,294

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$222,520	288	+2.5%	Shares	Sole	2026-04-27
2025-12-31	$216,895	281	-63.9%	Shares	Sole	2026-01-27
2024-06-30	$818,752	779	0.0%	Shares	Sole	2024-07-11
2024-03-31	$749,779	779	-10.8%	Shares	Sole	2024-04-02
2023-12-31	$766,747	873	-26.2%	Shares	Sole	2024-01-02
2023-09-30	$973,561	1,183	-12.1%	Shares	Sole	2023-10-10
2023-06-30	$967,154	1,346	-23.0%	Shares	Sole	2023-07-05
2023-03-31	$1,437,100	1,749	+10.3%	Shares	Sole	2023-04-03
2022-12-31	$1,143,561	1,585	-4.7%	Shares	Sole	2023-01-06
2022-09-30	$1,146,279	1,664	+8.8%	Shares	Sole	2022-10-03
2022-06-30	$904,428	1,530	-39.6%	Shares	Sole	2022-07-11
2022-03-31	$1,768,399	2,532	+182.9%	Shares	Sole	2022-04-04
2021-12-31	$565,210	895	0.0%	Shares	Sole	2022-01-11
2021-09-30	$541,636	895	+9.8%	Shares	Sole	2021-10-18
2021-06-30	$455,210	815	+37.4%	Shares	Sole	2021-07-07
2021-03-31	$280,572	593	-47.6%	Shares	Sole	2021-05-03
2020-12-31	$546,880	1,132	-44.6%	Shares	Sole	2021-02-18
2020-09-30	$1,144,190	2,044	+78.4%	Shares	Sole	2020-11-03
2020-06-30	$714,702	1,146	—	Shares	Sole	2020-07-20
No filing history on record for this holder in this stock.